Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.52 |
| ▸ | BRD4 | O60885 | 11/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9290357 | 0.85 | PKM (0.49) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL9290362 | 0.83 | MEN1 (0.70) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL13009257 | 0.81 | KMT2A (0.56) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL4857545 | 0.81 | KMT2A (0.56) | MEN1KMT2AUSP2KEAP1NFE2L2 | |
| SCHEMBL9290356 | 0.80 | BRD4 (0.50) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL12869518 | 0.80 | KMT2A (0.63) | PKMMEN1KMT2AUSP2KEAP1 | |
| SCHEMBL12869514 | 0.79 | KMT2A (0.57) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL1101925 | 0.79 | KMT2A (0.62) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL9290415 | 0.79 | BRD4 (0.58) | PKMBRD4MEN1KMT2AUSP2 | |
| SCHEMBL9290409 | 0.78 | BRD4 (0.48) | PKMBRD4MEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2695930-B1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE, NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | DAINIPPON INK & CHEMICALS (JP) | 2019-09-11 | — | — | EP | disclosed |
| US-9475991-B2 | Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative | ADEKA CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| US-9475991-B2 | Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative | ADEKA CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| US-20130334461-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | ADEKA CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-20130334461-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE | ADEKA CORPORATION (JP) | 2013-12-19 | — | — | US | disclosed |
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2458941-A1 | OPTICAL FILTER | Adeka Corporation (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152538-A1 | OPTICAL FILTER | C1R, CBR3, CBR1 | PKM 1698/4885BRD4 3880/4885MEN1 3537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.